procurement
12.06.2017
Sergey Puzyrevskiy: the Ulyanovsk region can become a pilot region to pursue the key areas of the National Competition Development Planmore![Sergey Puzyrevskiy: the Ulyanovsk region can become a pilot region to pursue the key areas of the National Competition Development Plan](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/archive/Ulyanovsk.jpeg)
FAS and the Government of the Ulyanovsk region developed and signed a plan on implementing the Agreement on Cooperation
more
![FAS won a Court hearing on concession for constructing a highway in Bashkiria](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/image-26.jpeg)
The Court confirmed that 100% financing of a concession agreement by the government is unlawful
more
06.06.2017
Sergey Puzyrevskiy: FAS will transfer the tariff-setting procedure into an electronic formmore![Sergey Puzyrevskiy: FAS will transfer the tariff-setting procedure into an electronic form](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/image-31.jpeg)
Consumers will be able to see the costs of natural monopolies included in the tariff
more
![ICN experts exchanged experience of countering bid-rigging](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/lori-0004338811-smallwww.jpg)
It is necessary to create and maintain conditions for pro-competitive vector of the parties involved in public procurement
more
26.05.2017
FAS: the support system for Russian pharmaceutical companies should not be build up on restricting the number of biddersmore![FAS: the support system for Russian pharmaceutical companies should not be build up on restricting the number of bidders](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/6a046a95-2349-4cb8-8d5b-7b48cf7f9590.jpg)
Russian pharmaceutical manufacturers should be supported through reducing administrative costs and developing export
more